Additionally, the IGF-1R inhibitor PQIP diminishes the breast cancer cell-induced osteolysis in a bone metastasis mouse model by inhibiting the IGF-1/IGF-1R/AKT axis-dependent osteoclast formation [72]. The gene discussed is IGF1R; the disease is breast carcinoma.